[Is it correct to use in first instance the new beta lactams and the latest aminoglycosides in the therapy of all acute bronchopneumopathies?].
D000208:Acute Disease; D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001996:Bronchopneumonia / Q000188:drug therapy*; D006801:Humans; D047090:beta-Lactams
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D047090:beta-Lactams
E corretto impiegare in prima istanza le nuove betalattamine e gli ultimi aminoglicosidi nella terapia di tutte le broncopneumopatie acute?